{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:57:54Z","timestamp":1787018274942,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>HIV\u2013tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is an immunopathological reaction to mycobacterial antigens induced by antiretroviral therapy. Prednisone reduces morbidity in TB-IRIS, but the mechanisms are unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the effect of prednisone on the inflammatory response in TB-IRIS (antigen-specific effector T cells, cytokines, and chemokines).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Blood was taken from participants in a randomized placebo-controlled trial of prednisone for TB-IRIS, at 0, 2, and 4 weeks. Participants received prednisone at a dosage of 1.5 mg\/kg\/day for 2 weeks followed by 0.75 mg\/kg\/day for 2 weeks, or placebo at identical dosages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Analyses included IFN-\u03b3 enzyme-linked immunospot (ELISPOT), reverse transcription-polymerase chain reaction on peripheral blood mononuclear cells after restimulation with heat-killed Mycobacterium tuberculosis, Luminex multiplex cytokine analysis of corresponding tissue culture supernatants, and Luminex multiplex cytokine analysis of serum. Fifty-eight participants with TB-IRIS (31 receiving prednisone, 27 receiving placebo) were included. In serum, significant decreases in IL-6, IL-10, IL-12 p40, tumor necrosis factor-\u03b1, IFN-\u03b3, and IFN-\u03b3\u2013induced protein-10 concentrations during prednisone, but not placebo, treatment were observed. No differences in ELISPOT responses comparing prednisone and placebo groups were shown in response to ESAT-6 (early secreted antigen target-6), Acr1, Acr2, 38-kD antigen, or heat-killed H37Rv M. tuberculosis. Purified protein derivative ELISPOT responses increased over 4 weeks in the prednisone group and decreased in the placebo group (P = 0.007).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The beneficial effects of prednisone in TB-IRIS appear to be mediated via suppression of predominantly proinflammatory cytokine responses of innate immune origin, not via a reduction of the numbers of antigen-specific T cells in peripheral blood.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201201-0094oc","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T02:00:33Z","timestamp":1339725633000},"page":"369-377","source":"Crossref","is-referenced-by-count":68,"title":["Corticosteroid-modulated Immune Activation in the Tuberculosis Immune Reconstitution Inflammatory Syndrome"],"prefix":"10.1093","volume":"186","author":[{"given":"Graeme","family":"Meintjes","sequence":"first","affiliation":[{"name":"Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, and"},{"name":"Department of Medicine"},{"name":"GF Jooste Hospital, Cape Town, South Africa"},{"name":"Department of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keira H.","family":"Skolimowska","sequence":"additional","affiliation":[{"name":"Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin A.","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, and"},{"name":"National Institute for Medical Research, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerryn","family":"Matthews","sequence":"additional","affiliation":[{"name":"Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Tadokera","sequence":"additional","affiliation":[{"name":"Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anali","family":"Conesa-Botella","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine, and"},{"name":"Department of Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnett","family":"Seldon","sequence":"additional","affiliation":[{"name":"Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molebogeng X.","family":"Rangaka","sequence":"additional","affiliation":[{"name":"Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Rebe","sequence":"additional","affiliation":[{"name":"Department of Medicine"},{"name":"GF Jooste Hospital, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique J.","family":"Pepper","sequence":"additional","affiliation":[{"name":"Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Morroni","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Unit, School of Public Health and Family Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Colebunders","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine, and"},{"name":"Department of Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, and"},{"name":"Department of Medicine"},{"name":"GF Jooste Hospital, Cape Town, South Africa"},{"name":"Department of Medicine, Imperial College London, London, United Kingdom"},{"name":"National Institute for Medical Research, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"key":"2026032101010916600_bib1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/429317","article-title":"Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis","volume":"40","author":"Hawkey","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026032101010916600_bib2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10096-003-0998-z","article-title":"Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients","volume":"22","author":"Cheng","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026032101010916600_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"2026032101010916600_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ccm.2009.08.013","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy","volume":"30","author":"Meintjes","year":"2009","journal-title":"Clin Chest Med"},{"key":"2026032101010916600_bib5","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/497269","article-title":"Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up","volume":"41","author":"Phillips","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026032101010916600_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.47276\/lr.79.4.372","article-title":"Leprosy type 1 (reversal) reactions and their management","volume":"79","author":"Walker","year":"2008","journal-title":"Lepr Rev"},{"key":"2026032101010916600_bib7","first-page":"121","article-title":"Advances in the treatment of reactions in leprosy","volume":"79","author":"Girdhar","year":"2007","journal-title":"Indian J Lepr"},{"key":"2026032101010916600_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/heart.84.2.183","article-title":"Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients","volume":"84","author":"Hakim","year":"2000","journal-title":"Heart"},{"key":"2026032101010916600_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(88)92415-4","article-title":"Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei","volume":"2","author":"Strang","year":"1988","journal-title":"Lancet"},{"key":"2026032101010916600_bib10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJMoa040573","article-title":"Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults","volume":"351","author":"Thwaites","year":"2004","journal-title":"N Engl J Med"},{"key":"2026032101010916600_bib11","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS"},{"key":"2026032101010916600_bib12","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/01.aids.0000202648.18526.bf","article-title":"Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients","volume":"20","author":"Bourgarit","year":"2006","journal-title":"AIDS"},{"key":"2026032101010916600_bib13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1086\/644784","article-title":"Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy","volume":"200","author":"Elliott","year":"2009","journal-title":"J Infect Dis"},{"key":"2026032101010916600_bib14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1164\/rccm.200806-858OC","article-title":"Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis\u2013associated immune reconstitution inflammatory syndrome","volume":"178","author":"Meintjes","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101010916600_bib15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1183\/09031936.00091010","article-title":"Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome","volume":"37","author":"Tadokera","year":"2011","journal-title":"Eur Respir J"},{"key":"2026032101010916600_bib16","author":"Meintjes"},{"key":"2026032101010916600_bib17","first-page":"31","article-title":"Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults","volume":"10","author":"Wilson","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026032101010916600_bib18","first-page":"517","article-title":"Evaluation of a diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV-infected adults","volume":"97","author":"Saranchuk","year":"2007","journal-title":"S Afr Med J"},{"key":"2026032101010916600_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1086\/499311","article-title":"Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens","volume":"193","author":"Wilkinson","year":"2006","journal-title":"J Infect Dis"},{"key":"2026032101010916600_bib20","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1128\/IAI.73.5.2991-2998.2005","article-title":"Efficient ex vivo stimulation of Mycobacterium tuberculosis\u2013specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids","volume":"73","author":"Wilkinson","year":"2005","journal-title":"Infect Immun"},{"key":"2026032101010916600_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/426139","article-title":"Ex vivo characterization of early secretory antigenic target 6\u2013specific T cells at sites of active disease in pleural tuberculosis","volume":"40","author":"Wilkinson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026032101010916600_bib22","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"2026032101010916600_bib23","first-page":"145","article-title":"Molecular mechanisms of corticosteroid actions","volume":"2","author":"Payne","year":"2001","journal-title":"Paediatr Respir Rev"},{"key":"2026032101010916600_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/QAD.0b013e32831d2a98","article-title":"Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"2026032101010916600_bib25","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1086\/657082","article-title":"Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy","volume":"202","author":"Oliver","year":"2010","journal-title":"J Infect Dis"},{"key":"2026032101010916600_bib26","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"2026032101010916600_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4049\/jimmunol.175.1.579","article-title":"The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses","volume":"175","author":"Simmons","year":"2005","journal-title":"J Immunol"},{"key":"2026032101010916600_bib28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/clinids\/21.4.924","article-title":"Concentrations of interferon \u03b3, tumor necrosis factor \u03b1, and interleukin-1\u03b2 in the cerebrospinal fluid of children treated for tuberculous meningitis","volume":"21","author":"Donald","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2026032101010916600_bib29","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/427995","article-title":"Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda","volume":"191","author":"Mayanja-Kizza","year":"2005","journal-title":"J Infect Dis"},{"key":"2026032101010916600_bib30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2147\/TCRM.S3470","article-title":"Interleukin-6 inhibitors in the treatment of rheumatoid arthritis","volume":"4","author":"Hennigan","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"2026032101010916600_bib31","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/592695","article-title":"Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes","volume":"47","author":"Blackmore","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/186\/4\/369\/67247076\/ajrccm_186_4_369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/186\/4\/369\/67247076\/ajrccm_186_4_369.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:01:17Z","timestamp":1774069277000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/186\/4\/369\/8507642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,8,15]]},"published-print":{"date-parts":[[2012,8,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201201-0094oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,8]]},"published":{"date-parts":[[2012,8]]}}}